Show simple record

dc.contributor.authorBowles, Danielle
dc.contributor.authorRobson, Mark
dc.contributor.authorGalloway, Pru
dc.contributor.authorWalker, Lyndon
dc.description.abstractOBJECTIVES: To determine owners’ perception of their pet’s quality of life during treatment with carboplatin for a variety of canine and feline neoplasms. METHODS: Owners were contacted via a postal questionnaire and asked questions regarding their perception of chemotherapy in pets and their perception of carboplatin treatment in their pet. RESULTS: Twenty-eight (59%) of owners responded to the questionnaire. Forty-three percent of owners had not considered chemotherapy in pets before treatment; however, after treatment, 89% of owners supported its use. Sixteen (57%) patients had mild to severe side effects. Most patients experienced mild side effects, including lethargy and loss of appetite. Quality of life during treatment was reduced compared with prediagnosis quality of life however at its best was significantly improved compared with pretreatment quality of life. Eighty-nine per cent of respondents did not regret treating their pet. CLINICAL SIGNIFICANCE: Carboplatin is well tolerated by both owners and pets. Most patients have either no side effects or experience mild lethargy or inappetence. Carboplatin treatment, either alone or in conjunction with other medications, should be considered as a palliative treatment in both dogs and cats with susceptible neoplasms.en_NZ
dc.rightsThe definitive version of this article is available at
dc.subjectquality of lifeen_NZ
dc.subjectpalliative careen_NZ
dc.subjectfeline neoplasmen_NZ
dc.subjectcanine neoplasmen_NZ
dc.titleOwners’ perception of carboplatin in conjunction with other palliative treatments for cancer therapyen_NZ
dc.typeJournal Articleen_NZ
dc.rights.holderBritish Small Animal Veterinary Associationen_NZ
dc.subject.marsden070706 Veterinary Medicineen_NZ
dc.identifier.bibliographicCitationBowles, D., Robson, M., Galloway, P., & Walker, L. (2010). Owners’ perception of carboplatin in conjunction with other palliative treatments for cancer therapy. Journal of Small Animal Practice, 51(2), 104–112. doi: 10.1111/j.1748-5827.2009.00891.xen_NZ
unitec.institutionUnitec Institute of Technologyen_NZ
unitec.publication.titleJournal of Small Animal Practiceen_NZ
dc.contributor.affiliationUnitec Institute of Technologyen_NZ
unitec.institution.studyareaNatural Sciences

Files in this item


This item appears in

Show simple record

 Unitec Institute of Technology, Private Bag 92025, Victoria Street West, Auckland 1142